Media Contact

Sites are often asked to adapt to sponsor and CRO processes that sit outside their day-to-day workflows. What if we took a different approach? Join Brian Mallon (ICON), Scott Uebele (Advarra), Denise Snyder (Duke Univer...

The first EU Joint Clinical Assessments (JCAs) may reduce some duplication in clinical assessments, but they are also creating new challenges for evidence planning. Mia Malmenäs of ICON notes that manufacturers are navi...

Companies that have not historically developed biosimilars are recognising the opportunity represented by recent regulatory changes. Discover how the biosimilars market is being impacted and how developers can help the...

Latest issue now available. Join thousands of subscribers who have discovered the convenience of our free monthly publication, by signing up today https://ow.ly/Hxx750Zi8bm. Compiled and collated by ICON’s Regulatory ...

Join us tomorrow at the SCDM India Single Day Event in Hyderabad, where ICON's Gangotri Boni will serve as Event Co Chair and lead the session, 'Transforming information into insights'. Discover how data can be transfo...

To mark International Yoga Day, colleagues across India took part in Desktop Yoga Week, a wellbeing initiative designed to encourage simple moments of movement and mindfulness during the working day. More than 850 colle...

Last week, we officially relocated our Guangzhou office, marking an exciting milestone for our growing team in China. The new workspace offers upgraded facilities, a modern working environment, improved accessibility, a...

Join us at this year's SCDM India Single Day Event on 11 July in Hyderabad, where ICON's Gangotri Boni will be serving as Event Co Chair and chairing the session, 'Transforming information into insights'. Discover how ...

We are proud to be recognised once again by TIME as one of the World’s Most Sustainable Companies 2026. This marks the second consecutive year ICON has received this prestigious accolade, reflecting our continued commit...

Biosimilar development is entering a more complex and competitive era. From advanced biologic modalities to evolving regulatory expectations, success now depends on building flexibility and rigour into development strate...

Critical care trials present unique challenges—from narrow enrolment windows and surrogate consent to rapidly changing patient conditions—requiring thoughtful design aligned with the realities of ICU care. Learn more: h...

Colleagues in Chennai recently came together for the inaugural Q2 Fun Event, organised by the India Employee Recreation Club. Held at the Chennai amphitheatre, the event welcomed around 600 employees for an afternoon of...